Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
All content for UKMFA is the property of Ian and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
Dr Liz Evans & Sally Beck: Reporting on Medical Ethics & Modern Journalism
UKMFA
1 hour 12 minutes
9 months ago
Dr Liz Evans & Sally Beck: Reporting on Medical Ethics & Modern Journalism
Disclaimer: https://rumble.com/v6056un-ukmfa-disclaimer.html In this conversation, Ian Humphreys introduces Dr Liz Evans and journalist and best selling author, Sally Beck, to discuss the evolution of media reporting on vaccines, particularly in the context of COVID-19. Sally shares her journey as a journalist, highlighting the challenges faced in addressing vaccine injuries and the influence of Big Pharma on health narratives. The discussion emphasises the importance of informed consent and ...
UKMFA
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
